Skip to main content
logo
Helix BioPharma Corp. (TSX:HBP)
Canada flag Canada · Delayed Price · Currency is CAD
1.870
+0.070 (3.89%)
Aug 14, 2026, 2:47 PM EST

Helix BioPharma Financials Overview

Millions CAD. Fiscal year is Aug - Jul.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Operating Income
-3.26-5.4-9.24-6.33-6.04-9.13
Net Income
-3.32-5.21-9.26-6.29-6.56-8.04
Earnings Per Share
-0.04-0.09-0.21-0.16-0.22-0.29
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Cash & Investments
2.840.071.080.813.253.57
Total Debt
0.360.34--2.473.61
Net Cash (Debt)
2.48-0.271.080.810.78-0.05
Net Cash Growth
247.13%-33.79%3.06%--
Net Cash Per Share
0.03-0.000.020.020.03-0.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Operating Cash Flow
-3.21-3.83-5.22-5.53-6.51-9.3
Capital Expenditures
--0-0.01-0.01--
Free Cash Flow
-3.21-3.83-5.23-5.54-6.51-9.3
Free Cash Flow Growth
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21
Forward PE
-10.0010.0010.0010.0010.00